Qiagen NV at Morgan Stanley Global Healthcare Conference Transcript
So welcome, everyone, and a warm welcome to our fireside chat today hosted by the MS Global Healthcare Conference. I'm [Aisha Noor] from the European MedTech team here at Morgan Stanley, and I'm very pleased to be joined today by Thierry Bernard, CEO of QIAGEN. This session will take approximately 30 minutes, and you can participate with your questions for this session by just raising your hand, and I'll let you speak. With that, welcome Thierry, and thank you for joining us today.
Questions & Answers
Maybe if we start off with your 5 pillars of growth, starting off with sample tech. I mean, growth in your sample tech business, especially even in the non-COVID segment, was relatively strong in the first half. How much of that would you attribute to market recovery versus market share gains? And how sustainable do you think that is going forward?
Thanks, and thanks for your attention and for coming this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |